Plasma Fractionation Market size to reach $23 billion by 2027, registering a CAGR of 6.2% from 2020 to 2027. The report offers an in-depth analysis of the market size, emerging and current trends, future estimations, and key players.
A major factor driving the growth of the market is the increase in the aging population worldwide, which is at risk of various rare diseases that require the use of plasma derivatives. Moreover, increasing use of immunoglobulins and alpha-1-antitrypsin in the pharmaceutical sector worldwide is also fueling the growth of the plasma fractionation market. The growth in plasma collection centers across the globe is another major factor contributing to the growth of the market.
- The outbreak of COVID-19 pandemic has led to a decrease in number of blood donations and plasma collections, which hampers the plasma fractionation market as it leads to shortage of in raw material supply.
- Decrease in raw material supply was compensated by the fall in demand for plasma derivatives in the starting of nationwide lockdowns, as the elective surgical procedures were postponed and availability of treatment for other medical conditions was also hampered.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/request-sample/943
By product, immunoglobulin is the largest segment in the plasma fractionation market and is also expected to exhibit the fastest growth rate during the forecast period. The growth of this segment is attributed to various applications of immunoglobulins in various disorders such as primary and secondary immunodeficiencies, autoimmune diseases and inflammatory diseases.
By region, the private sector accounted for the largest share of the plasma fractionation market during the forecast period. There are many private players operating in the plasma fractionation industry who collect and fractionate large quantities of plasma into derivatives like albumin, immunoglobulin and others. Thus, it contributes to the growth of the market.
Based on region, North America accounts for the major share due to easy availability of plasma fractionation products, increase in number of plasma collection centers and presence of major players offering plasma fractionation products. Asia-Pacific is expected to witness the fastest growth during the forecast period due to increasing awareness about the use of plasma fractionation products and increasing disposable income.
𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲: https://www.alliedmarketresearch.com/purchase-enquiry/943
𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬:
- Bio product laboratory,
- Biotest AG,
- Takeda Pharmaceutical Company Limited,
- CSL Ltd.,
- Grifols SA,
- Kedrion S.P.A (Kedrion Biopharma Inc.),
- LFB S. A.,
- Octapharma AG,
- Baxter International Inc.,
- Sanquin Blood Supply Foundation.
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
205, Portland, OR 97220
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060